These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8742805)

  • 21. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.
    Martinez D; Narendran R; Foltin RW; Slifstein M; Hwang DR; Broft A; Huang Y; Cooper TB; Fischman MW; Kleber HD; Laruelle M
    Am J Psychiatry; 2007 Apr; 164(4):622-9. PubMed ID: 17403976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement.
    Bozarth MA; Wise RA
    NIDA Res Monogr; 1986; 67():190-6. PubMed ID: 3092066
    [No Abstract]   [Full Text] [Related]  

  • 23. The dopamine hypothesis of the reinforcing properties of cocaine.
    Kuhar MJ; Ritz MC; Boja JW
    Trends Neurosci; 1991 Jul; 14(7):299-302. PubMed ID: 1719677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural mechanisms of drug reinforcement.
    Koob GF
    Ann N Y Acad Sci; 1992 Jun; 654():171-91. PubMed ID: 1632582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivation of extended behaviors by anterior cingulate cortex.
    Holroyd CB; Yeung N
    Trends Cogn Sci; 2012 Feb; 16(2):122-8. PubMed ID: 22226543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychopharmacological models of drug dependence. Key role of the dopaminergic mesolimbic system].
    Wallnöfer A
    Schweiz Rundsch Med Prax; 1993 Sep; 82(37):999-1003. PubMed ID: 8210861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rat mesoaccumbocingulate dopaminergic system and brain emotional functions].
    Droblenkov AV; Karelina NR; Lebedev VA
    Morfologiia; 2008; 134(6):84-9. PubMed ID: 19241878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for studying the neurochemical substrates of drug reinforcement in rodents.
    Phillips AG; Broekkamp CL; Fibiger HC
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):585-90. PubMed ID: 6686695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine.
    Marinelli M; Piazza PV; Deroche V; Maccari S; Le Moal M; Simon H
    J Neurosci; 1994 May; 14(5 Pt 1):2724-31. PubMed ID: 8182438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical dopaminergic involvement in cocaine reinforcement.
    Goeders NE; Smith JE
    Science; 1983 Aug; 221(4612):773-5. PubMed ID: 6879176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine binding sites related to drug self-administration.
    Ritz MC; Boja JW; George FR; Kuhar MJ
    NIDA Res Monogr; 1989; 95():239-46. PubMed ID: 2561828
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs.
    Fischman MW
    NIDA Res Monogr; 1989; 92():211-30. PubMed ID: 2512494
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug motivation and abuse: a neurobiological perspective.
    Di Chiara G; Acquas E; Carboni E
    Ann N Y Acad Sci; 1992 Jun; 654():207-19. PubMed ID: 1632584
    [No Abstract]   [Full Text] [Related]  

  • 34. Mesocorticolimbic dopamine systems and reward.
    Fibiger HC; Phillips AG
    Ann N Y Acad Sci; 1988; 537():206-15. PubMed ID: 3059924
    [No Abstract]   [Full Text] [Related]  

  • 35. Reinforcement pathways for cocaine.
    Koob GF; Hubner CB
    NIDA Res Monogr; 1988; 88():137-59. PubMed ID: 3145446
    [No Abstract]   [Full Text] [Related]  

  • 36. Determinants of cocaine self-administration by laboratory animals.
    Woolverton WL
    Ciba Found Symp; 1992; 166():149-61; discussion 161-4. PubMed ID: 1638910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural responses to acute cocaine administration in the human brain detected by fMRI.
    Kufahl PR; Li Z; Risinger RC; Rainey CJ; Wu G; Bloom AS; Li SJ
    Neuroimage; 2005 Dec; 28(4):904-14. PubMed ID: 16061398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opponent process model and psychostimulant addiction.
    Koob GF; Caine SB; Parsons L; Markou A; Weiss F
    Pharmacol Biochem Behav; 1997 Jul; 57(3):513-21. PubMed ID: 9218276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo analysis of the role of dopamine in stimulant and opiate self-administration.
    Gratton A
    J Psychiatry Neurosci; 1996 Jul; 21(4):264-79. PubMed ID: 8754596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mesocorticolimbic dopamine system.
    Ann N Y Acad Sci; 1988; 537():1-540. PubMed ID: 3202542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.